|
1
|
Thomas NH: Diagnosis and management of
Guillain-Barré syndrome. Curr Paediatr. 15:287–291. 2005.
View Article : Google Scholar
|
|
2
|
Sejvar JJ, Baughman AL, Wise M and Morgan
OW: Population incidence of Guillain-Barré syndrome: A systematic
review and meta-analysis. Neuroepidemiology. 36:123–133. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bogliun G and Beghi E; Italian GBS
Registry Study Group, : Incidence and clinical features of acute
inflammatory polyradiculoneuropathy in Lombardy, Italy, 1996. Acta
Neurol Scand. 110:100–106. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fokke C, van den Berg B, Drenthen J,
Walgaard C, van Doorn PA and Jacobs BC: Diagnosis of Guillain-Barré
syndrome and validation of Brighton criteria. Brain. 137:33–43.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
van Doorn PA, Ruts L and Jacobs BC:
Clinical features, pathogenesis, and treatment of Guillain-Barré
syndrome. Lancet Neurol. 7:939–950. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lin JJ, Hsia SH, Wang HS, Lyu RK, Chou ML,
Hung PC, Hsieh MY and Lin KL: Clinical variants of Guillain-Barré
syndrome in children. Pediatr Neurol. 47:91–96. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yu JY, Jung HY, Kim CH, Kim HS and Kim MO:
Multiple cranial neuropathies without limb involvements:
Guillain-Barre syndrome variant. Ann Rehabil Med. 37:740–744. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lyu RK and Chen ST: Acute multiple cranial
neuropathy. A variant of Guillain-Barré syndrome. Muscle Nerve.
30:433–436. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sudulagunta SR, Sodalagunta MB, Sepehrar
M, Khorram H, Bangalore Raja SK, Kothandapani S, Noroozpour Z,
Aheta Sham M, Prasad N, Sunny SP, et al: Guillain-Barré syndrome:
Clinical profile and management. Ger Med Sci. 13:Doc16. 2015.
|
|
10
|
van den Berg B, Walgaard C, Drenthen J,
Fokke C, Jacobs BC and van Doorn PA: Guillain-Barré syndrome:
Pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol.
10:469–482. 2010. View Article : Google Scholar
|
|
11
|
Rafii MS: Case 14: A woman with bilateral
Bell's palsy. Med Gen Med. 8:232006.
|
|
12
|
Bogousslavsky J and Fisher M: Textbook of
neurology. Butterworth-Heinemann Co; pp. 1–18. 1998
|
|
13
|
Peskind ER, Riekse R, Quinn JF, Kaye J,
Clark CM, Farlow MR, Decarli C, Chabal C, Vavrek D, Raskind MA and
Galasko D: Safety and acceptability of the research lumbar
puncture. Alzheimer Dis Assoc Disord. 19:220–225. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Morley JB and Reynolds EH: Papilloedema
and the Landry-Guillain-Barré syndrome. Case reports and a review.
Brain. 89:205–222. 1966. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Deshmukh IS, Bang AB, Jain MA and Vilhekar
KY: Concurrent acute disseminated encephalomyelitis and
Guillain-Barre syndrome in a child. J Pediatr. Neurosci. 10:61–63.
2015.
|
|
16
|
Incecik F, Herguner OM, Besen S, Yar K and
Altunbasak S: Guillain-Barré syndrome with hyperreflexia and
bilateral papillitis in a child. J Pediatr Neurosci. 11:71–73.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hughes RA, Swan AV and van Doorn PA:
Intravenous immunoglobulin for Guillain-Barré syndrome. Cochrane
Database Syst Rev: CD002063. 2014. View Article : Google Scholar
|
|
18
|
Raphaël JC, Chevret S, Hughes RA and
Annane D: Plasma exchange for Guillain-Barré syndrome. Cochrane
Database Syst Rev: CD001798. 2012. View Article : Google Scholar
|
|
19
|
Edvardsson B and Persson S: Polyneuritis
cranialis presenting with anti-GQ1b IgG antibody. J Neurol Sci.
281:125–126. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ali N, Rampure R, Malik F, Jafri SI and
Amberker D: Guillain-Barré syndrome occurring synchronously with
systemic lupus erythematosus as initial manifestation treated
successfully with low-dose cyclophosphamide. J Community Hosp
Intern Med Perspect. 6:306892016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Silburn S, McIvor E, McEntegart A and
Wilson H: Guillain-Barré syndrome in a patient receiving
anti-tumour necrosis factor alpha for rheumatoid arthritis: A case
report and discussion of literature. Ann Rheum Dis. 67:575–576.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hara M: Intravenous immunoglobulin (IVIG).
Nihon Rinsho. 67:599–605. 2009.(In Japanese). PubMed/NCBI
|
|
23
|
Kusunoki S: Neuroimmunological diseases:
Update. Nihon Rinsho. 71:771–777. 2013.(In Japanese). PubMed/NCBI
|
|
24
|
Hughes RA: Intravenous immunoglobulin for
chronic inflammatory demyelinating polyradiculoneuropathy: The ICE
trial. Expert Rev Neurother. 9:789–795. 2009. View Article : Google Scholar : PubMed/NCBI
|
